PharmaShots | Incisive News in 3 Shots

Subscribe Now

Myovant Sciences

Myovant and Pfizer’s Myfembree Receive the US FDA’s Approval for the Treatment of Pain Associated with Endometriosis

Myovant and Pfizer’s Myfembree Receive the US FDA’s Approval for the Treatment of Pain Associated with Endometriosis

August 8, 2022

Myovant Sciences’ Orgovyx (relugolix) Receive EC’s Approval for the Treatment of Advanced Hormone-Sensitive Prostate Cancer

Myovant Sciences’ Orgovyx (relugolix) Receive EC’s Approval for the Treatment of Advanced Hormone-Sensitive Prostate Cancer

April 29, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us